Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,151–6,175 of 7,816 matching trials · page 247 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
LESCOD: "Lewy Body Screening in Cognitive Disorders" NCT02263287 LeSCoD scale Runs in: France · 1 site |
NA other |
TERMINATED | 133 | Nantes University Hospital OTHER |
2017-12-07 |
|
1-hour Post-load Hyperglycemia and Mild Cognitive Impairment NCT03363516 Cerebral 3 Tesla MRI Runs in: Italy · 1 site |
NA other |
UNKNOWN | 30 | Maria Perticone OTHER |
2017-12-07 |
|
A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma NCT00201669 Clofarabine Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 6 | Ohio State University Comprehensive Cancer Center OTHER |
2017-12-06 |
|
CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease NCT02021682 Runs in: United States · 1 site |
NA other |
COMPLETED | 58 | Washington University School of Medicine OTHER |
2017-12-05 |
|
Effectiveness of Flash Mediation Therapy NCT02933177 2 months control condition - 4 months chariot-flash; 4 months contr... Runs in: France · 1 site |
NA other |
COMPLETED | 241 | Hospices Civils de Lyon OTHER |
2017-12-02 |
|
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease NCT00843518 LY451395; Placebo Runs in: United States · 17 sites |
PHASE2 other |
COMPLETED | 132 | Eli Lilly and Company INDUSTRY |
2017-11-29 |
|
Treatment of Posttraumatic Stress Disorder and Aggressive Behavior in Soldiers and Ex-combatants NCT02242136 FORNET Runs in: Burundi · 1 site |
NA other |
COMPLETED | 56 | University of Konstanz OTHER |
2017-11-29 |
|
Decreasing Youth Involvement in Violence in Burundi NCT02503488 Narrative Exposure Therapy for Forensic Offender Rehab; Treatment as Usual Runs in: Burundi · 1 site |
NA other |
COMPLETED | 40 | University of Konstanz OTHER |
2017-11-29 |
|
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease NCT00348309 Rosiglitazone Extended Release 2mg; Rosiglitazone Extended Release ... Runs in: Argentina; Austria; Brazil; Canada; Chile; Czechia; Franc... · 249 sites |
NA symptomatic-cholinergic |
COMPLETED | 1,496 | GlaxoSmithKline INDUSTRY |
2017-11-28 |
|
Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease NCT01451463 Runs in: United States · 1 site |
NA other |
COMPLETED | 11 | Ohio State University OTHER |
2017-11-24 |
|
Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease NCT02912169 Liposuction under local anesthesia; Infusion of AD-SVF via IV and I... Runs in: United States · 1 site |
PHASE1|PHASE2 other |
WITHDRAWN | 0 | Ageless Regenerative Institute INDUSTRY |
2017-11-24 |
|
Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia NCT02078310 ITI-007; Placebo; ITI-007; Placebo Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 35 | Intra-Cellular Therapies, Inc. INDUSTRY |
2017-11-17 |
|
Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease NCT02197130 PF-02545920; PF-02545920; Placebo Runs in: Canada; Germany; Poland; United Kingdom; United States · 57 sites |
PHASE2 other |
COMPLETED | 272 | Pfizer INDUSTRY |
2017-11-17 |
|
Retaining Cognition While Avoiding Late-Life Depression NCT01886586 Problem Solving Therapy; Problem Solving Therapy + Exercise; Enhanc... Runs in: United States · 2 sites |
NA other |
COMPLETED | 94 | University of Pittsburgh OTHER |
2017-11-14 |
|
Effects of Tai-chi Programme on Mobility of People With Dementia NCT03341091 Tai-chi group Runs in: Hong Kong · 2 sites |
NA other |
COMPLETED | 26 | The Hong Kong Polytechnic University OTHER |
2017-11-14 |
|
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers NCT00490568 Rosiglitazone XR Runs in: Argentina; Australia; Austria; Belgium; Bulgaria; Canada;... · 272 sites |
PHASE3 other |
TERMINATED | 1,461 | GlaxoSmithKline INDUSTRY |
2017-11-13 |
|
Cataract Removal and Alzheimer's Disease NCT00921297 Immediate Cataract Surgery Runs in: United States · 2 sites |
NA other |
COMPLETED | 122 | University Hospitals Cleveland Medical Center OTHER |
2017-11-09 |
|
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers NCT00550420 Rosiglitazone XR Runs in: Austria; Bulgaria; Chile; China; Croatia; Estonia; German... · 70 sites |
PHASE3 other |
TERMINATED | 331 | GlaxoSmithKline INDUSTRY |
2017-11-08 |
|
Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy NCT03330353 Pupillometry Runs in: United States · 1 site |
NA other |
UNKNOWN | 56 | Massachusetts General Hospital OTHER |
2017-11-07 |
|
Women's Health Initiative Study of Cognitive Aging NCT00631332 Runs in: United States · 1 site |
NA other |
COMPLETED | 2,303 | Wake Forest University OTHER |
2017-11-06 |
|
Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm NCT01124773 Runs in: United States · 1 site |
NA other |
COMPLETED | 1,362 | Wake Forest University Health Sciences OTHER |
2017-11-06 |
|
Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers NCT01273272 Comprehensive, CBT-based, multi-component treatment; Treatment as usual Runs in: Switzerland · 1 site |
PHASE2 other |
COMPLETED | 50 | University of Zurich OTHER |
2017-11-06 |
|
Central and Systemic Inflammation in Alzheimer's Disease NCT01775696 Runs in: France · 1 site |
NA other |
COMPLETED | 125 | Assistance Publique - Hôpitaux de Paris OTHER |
2017-11-06 |
|
Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease NCT02221947 Bryostatin 1; Placebo Runs in: United States · 1 site |
PHASE1|PHASE2 other |
TERMINATED | 9 | Neurotrope Bioscience, Inc. INDUSTRY |
2017-11-06 |
|
Does Computerized Cognitive Training Improve Executive Functioning in the Older Adult? NCT03170492 RehaCom Computerized Cognitive Training for 480 minutes; Pencil-and... Runs in: United States · 1 site |
NA other |
UNKNOWN | 20 | University of the Sciences in Philadelphia OTHER |
2017-11-06 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial